OUR FIRM

Latest News

April 17, 2015

Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of William Tanner as a Managing Director and senior biotech research analyst.

Mr. Tanner will start work at Guggenheim in May 2015 in the firm’s New York office.

“Bill brings a wealth of biotech experience, in both investment and academic research, to our experienced and highly acclaimed healthcare team,” said Matthew Johnson, Senior Managing Director and Head of Equities at Guggenheim Securities. “Bill will join a healthcare research team that includes, on the equities side, Tony Butler in biopharmaceuticals and Louise Chen in specialty pharmaceuticals, and, on the government policy side, Rick Weissenstein in healthcare policy analysis in Washington.”

“Bill’s hiring is part of a highly-focused recent expansion of our research capabilities in such key sectors as tech-media-telecom, consumer, energy, and financial services,” said John Hervey, Senior Managing Director and Director of Research at Guggenheim Securities. “The goal is to continue to enhance our ability to help our clients achieve outstanding investment results.”

Mr. Tanner has worked nearly 20 years as a biotech analyst, including senior analyst roles at Leerink Swann and SG Cowen.

He holds a Bachelor of Science degree and a PhD in Physiology, both from Texas A&M University, as well as an MBA from Washington University’s Olin School of Business. Before embarking on his investment research career, Mr. Tanner worked as a post-doctoral research fellow at Monsanto Co. and as an NIH National Research Service Award fellow at Washington University School of Medicine.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.



July 29, 2021

Seth Sigman Joins Guggenheim Securities as Consumer Internet and eCommerce Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seth Sigman has joined the firm as a Managing Director and Research Analyst covering the consumer internet sector with a focus on e-commerce retailers and other digital first consumer product and service companies.

Read More

July 22, 2021

Jonathan Pritti and Andrew Redmond to Join Guggenheim Securities Healthcare Investment Banking

Guggenheim Securities announced today that Jonathan Pritti will join the firm as a Senior Managing Director and Andrew Redmond will join the firm as a Managing Director in its healthcare investment banking practice and will focus on covering healthcare-focused information technology companies.  Messrs. Pritti and Redmond will commence work at Guggenheim in September and will be based out of its New York office.

Read More

July 16, 2021

Guggenheim Securities Wins GlobalCapital’s Esoteric ABS Bank of the Year Award

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today it has been named the “Esoteric ABS Bank of the Year 2020” by capital markets publication GlobalCapital. This recognition follows Guggenheim’s win as “Best Securitization Bank of the Year” award for 2019 and “Most Innovative Securitization Bank of the Year” award for 2018.

Read More